This release carries particular significance as the company's first full quarter operating as Flyte Aviation. On October 5, 2026, the business previously known as Catheter Precision completed its rebrand, switched its NYSE American ticker from VTAK to VJET, and carried out a 1-for-10 reverse split. The changes formalized a shift away from legacy medical-device activities toward a technology-enabled private aviation model centered on an expanding fleet of Cirrus Vision Jets. In my view, the results offer an initial gauge of whether the aviation approach can grow rapidly enough to offset ongoing losses and cash consumption, an issue that has persisted through repeated annual shortfalls and a going-concern warning in the prior audit.
Flyte Aviation has already provided guidance on revenue. In mid-October, it reported record preliminary third-quarter revenue of $2.15 million, reflecting an increase of about 110% from the prior quarter and supported by its short-haul charter operations. From what I see, the focus now shifts to the complete income statement and cash-flow information.
Particular emphasis will fall on the net loss, operating cash flow, and rate of cash usage. In the second quarter of 2026, the company recorded a net loss of roughly $5.0 million—more than three dollars lost for each dollar of sales—and consumed about $5.7 million in cash from operations. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The previous audit had already highlighted substantial doubt about the company's ability to continue as a going concern, so any signs of reduced losses or steadier cash burn would stand out as important signals. Fleet utilization, booking trends, and results from its FAA Part 135 operating subsidiary are expected to receive attention in management's discussion.
Investor sentiment ahead of the report remains measured. The stock has traded with limited volume and notable volatility, and the October reverse split represented the company's second share consolidation in roughly fourteen months—a step that raises the nominal price without altering underlying fundamentals. Analysts have highlighted substantial operating losses, continued cash burn, and potential dilution from earlier convertible and equity financings as primary concerns.
At the same time, the aviation narrative shows forward movement, with management highlighting sequential revenue gains, fleet growth, and new partnerships. The market response will likely depend on whether the full third-quarter figures and any outlook comments strengthen that growth story or draw renewed focus to the losses that have accompanied it so far.
Looking beyond the third-quarter results, attention should turn to how quickly Flyte Aviation can translate revenue growth into a clearer path to profitability. The company runs a modest fleet of Cirrus Vision Jets under an FAA Part 135 air carrier certificate, and expanding that fleet while managing fixed costs and maintenance remains central to the business model.
Cash and liquidity also warrant close observation. Given the prior audit's going-concern flag and the company's history of repeated financings, any additional capital raises, convertible instruments, or share registrations for resale will influence the dilution picture. Shifts in working capital and operating cash flow will matter as much as the revenue figure itself.
Finally, the company continues to maintain its Life Sciences operations, including the LockeT and VIVO product lines. Management has indicated these will proceed without capital constraints, yet investors should track whether aviation growth absorbs the overall cost structure or whether legacy segments continue to pressure results. Fleet expansion, customer-acquisition expenses, and any updates to full-year guidance will serve as important points to follow after the report.
When preparing for reports like this one, I often turn to Tickeron’s AI Screener to quickly compare small-cap names and spot similar setups in the aviation and technology sectors. It helps filter by technical patterns, fundamentals, and performance metrics, saving time when evaluating rebranded or thinly traded companies alongside their peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
On November 10, 2026, the Stochastic Oscillator for VJET moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 70 instances where the indicator left the oversold zone. In 62 of the 70 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.
The RSI Indicator entered the oversold zone -- be on the watch for VJET's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +0.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where VJET advanced for three days, in 162 of 186 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VJET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VJET entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.332) is normal, around the industry mean (0.918). P/E Ratio (-0.506) is within average values for comparable stocks, (-5.910). VJET's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.572). Dividend Yield (0.000) settles around the average of (0.063) among similar stocks. P/S Ratio (0.178) is also within normal values, averaging (8.002).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. VJET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VJET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer and operater of industrial 3D printing systems
Industry AirFreightCouriers